Bioquell Regulatory News (BQE)

19 January, 2017

Bioquell PLC

Pre-close statement

Bioquell PLC ("Bioquell") (LSE symbol: BQE) - provider of specialist biodecontamination products and services for the international Life Sciences markets today announces an update on its trading performance prior to entering the closed period ahead of the preliminary results for the year to 31 December 2016.

We estimate that revenues for the year ended 31 December, 2016 will be broadly in line with market expectations at approximately £26.8 million (2015: £26.9 million)

This estimate comprises £25.5m for the core biodecontamination business (2015: £23.4m), representing growth of some 8.7% (1.3% at constant currency rates) and £1.3m for the defence business (2015: £3.5m) whose revenues fluctuate significantly from year to year.

Pre-exceptional earnings before tax are expected to be modestly ahead of market expectations.

The Company had net cash of £8.8m at the year end.

The preliminary results for the year ended 31 December, 2016 will be announced on 7 March, 2017.

- Ends -

Bioquell PLC 01264 835900

Ian Johnson Chairman

Michael Roller Finance Director